Lateral hypothalamic syndrome in rats: a comparison of the behavioral and neurochemical effects of lesions placed in the lateral hypothalamus and nigrostriatal bundle.
The effects of total (T-NSB) and subtotal (S-NSB) destruction of the nigrostriatal bundle were compared with the effects of large lateral hypothalamic (LH) lesions on various aspects of the lateral hypothalamic syndrome. The T-NSB and LH lesions produced equivalent decreases in caudate and telencephalic contents of dopamine and norepinephrine, while with the exception of telencephalic dopamine, S-NSB lesions had consistently smaller effect. The T-NSB and LH lesions produced equivalent effects on duration of aphagia and adipsia (Stages 1 to 3) and on long-term decreases in body weight and ad lib water consumption, and these effects were always greater than those produced by the S-NSB lesion. These aspects of the lateral hypothalamic syndrome appeared to be related to the interruption of the nigrostriatal bundle and consequent decrease in caudate dopamine. The T-NSB and S-NSB lesions produced equivalent long-term deficits in water regulation as measured by drinking in the absence of food or in response to intra- and extracellular dehydration, but these deficits were always significantly less than those produced by the LH lesion. It was concluded that these regulatory deficits were not related to destruction of catecholamine pathways. All three lesions totally blocked eating in response to a glucoprivic challenge. This aspect of the lateral hypothalamic syndrome, therefore, results from destruction of a small portion of the lateral diencephalon and may be related to the interruption of the dopaminergic mesolimbic system.
D000818:Animals; D001835:Body Weight; D001923:Brain Chemistry; D002421:Caudate Nucleus / Q000502:physiology*; D003681:Dehydration / Q000150:complications; D003847:Deoxyglucose / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D004327:Drinking Behavior / Q000502:physiology*; D005247:Feeding Behavior / Q000187:drug effects / Q000502:physiology*; D007031:Hypothalamus / Q000502:physiology*; D008032:Limbic System / Q000502:physiology; D008297:Male; D009434:Neural Pathways; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D013378:Substantia Nigra / Q000502:physiology*; D013687:Telencephalon / Q000378:metabolism
D003847:Deoxyglucose; D004298:Dopamine; D009638:Norepinephrine